🇺🇸 MRK — Merck & Co., Inc.
Salud CompraPrecio actual
146,73 USD
Máx. histórico
156,45
73 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-6,21%
Rango 52 semanas
85,24 – 156,92
Variación hoy
-0,14%
Cierre anterior
146,94
Rango de hoy
142,80 – 147,48
Volumen hoy
7.462.267
Peor caída histórica
-68,62%
28/12/2000 → 09/03/2009
Recuperado en 1796 días
Volatilidad anualizada ⓘ
25,43%
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Salud
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 148,21 (puede no estar actualizado)
- Dividend yield
- 2,31% (puede no estar actualizado)
- Precio objetivo analistas
- 161,53 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 14 horas
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 15/09/2026 | 0,8500 USD |
| 15/06/2026 | 0,8500 USD |
| 16/03/2026 | 0,8500 USD |
| 15/12/2025 | 0,8500 USD |
| 15/09/2025 | 0,8100 USD |
| 16/06/2025 | 0,8100 USD |
| 17/03/2025 | 0,8100 USD |
| 16/12/2024 | 0,8100 USD |
| 16/09/2024 | 0,7700 USD |
| 17/06/2024 | 0,7700 USD |
| 14/03/2024 | 0,7700 USD |
| 14/12/2023 | 0,7700 USD |
| 14/09/2023 | 0,7300 USD |
| 14/06/2023 | 0,7300 USD |
| 14/03/2023 | 0,7300 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 24/09/2013 | 45,45 | 46,01 | 45,34 | 45,35 | -0,31% | 1,47% | 13.939.029 |
| 23/09/2013 | 45,60 | 45,86 | 45,36 | 45,50 | -0,69% | 1,09% | 13.210.774 |
| 20/09/2013 | 46,12 | 46,18 | 45,68 | 45,81 | -0,52% | 1,10% | 29.303.128 |
| 19/09/2013 | 46,25 | 46,27 | 45,90 | 46,05 | -0,29% | 0,80% | 9.775.744 |
| 18/09/2013 | 45,62 | 46,48 | 45,45 | 46,18 | +0,81% | 2,26% | 14.681.118 |
| 17/09/2013 | 45,91 | 46,02 | 45,74 | 45,81 | -0,37% | 0,60% | 8.073.058 |
| 16/09/2013 | 46,04 | 46,23 | 45,90 | 45,98 | +0,84% | 0,73% | 9.880.754 |
| 13/09/2013 | 45,69 | 45,79 | 45,49 | 45,60 | -0,13% | 0,67% | 8.049.688 |
| 12/09/2013 | 45,61 | 45,78 | 45,47 | 45,66 | -0,60% | 0,69% | 9.958.515 |
| 11/09/2013 | 45,83 | 46,29 | 45,76 | 45,94 | +0,33% | 1,15% | 14.021.297 |
| 10/09/2013 | 45,67 | 46,18 | 45,67 | 45,78 | +0,50% | 1,13% | 32.287.413 |
| 09/09/2013 | 45,42 | 45,66 | 45,31 | 45,55 | +0,53% | 0,78% | 30.580.850 |
| 06/09/2013 | 45,39 | 45,63 | 44,90 | 45,31 | -0,04% | 1,60% | 27.944.815 |
| 05/09/2013 | 45,60 | 45,60 | 45,10 | 45,33 | -0,36% | 1,11% | 8.277.314 |
| 04/09/2013 | 44,97 | 45,69 | 44,95 | 45,50 | +1,00% | 1,63% | 11.596.330 |
| 03/09/2013 | 45,34 | 45,48 | 44,86 | 45,05 | -0,17% | 1,37% | 14.894.595 |
| 30/08/2013 | 44,93 | 45,31 | 44,87 | 45,12 | +0,40% | 0,98% | 8.725.962 |
| 29/08/2013 | 44,82 | 45,23 | 44,65 | 44,94 | +0,02% | 1,30% | 10.160.779 |
| 28/08/2013 | 44,64 | 45,23 | 44,34 | 44,93 | -0,04% | 1,99% | 10.283.186 |
| 27/08/2013 | 45,15 | 45,34 | 44,78 | 44,95 | -1,07% | 1,25% | 11.362.835 |
| 26/08/2013 | 45,61 | 45,71 | 45,35 | 45,44 | -0,23% | 0,77% | 9.662.770 |
| 23/08/2013 | 45,78 | 45,78 | 45,28 | 45,54 | -0,17% | 1,10% | 9.616.762 |
| 22/08/2013 | 45,45 | 45,78 | 45,23 | 45,62 | +0,74% | 1,22% | 9.044.554 |
| 21/08/2013 | 45,38 | 45,84 | 45,13 | 45,29 | -0,21% | 1,56% | 11.318.400 |
| 20/08/2013 | 45,47 | 46,16 | 45,38 | 45,38 | -0,04% | 1,72% | 14.771.560 |
| 19/08/2013 | 45,30 | 45,61 | 45,28 | 45,40 | -0,25% | 0,74% | 8.780.458 |
| 16/08/2013 | 45,60 | 45,80 | 45,31 | 45,52 | -0,56% | 1,09% | 13.834.019 |
| 15/08/2013 | 46,07 | 46,15 | 45,66 | 45,77 | -1,24% | 1,06% | 11.885.892 |
| 14/08/2013 | 46,33 | 46,53 | 46,19 | 46,35 | +0,29% | 0,72% | 8.940.383 |
| 13/08/2013 | 46,30 | 46,61 | 45,88 | 46,21 | -0,08% | 1,59% | 7.812.945 |